Open-Label Pilot Study of a Single Intra-Articular Injection of Mannitol-Modified Cross-Linked Hyaluronic Acid (HANOX-M-XL) for the Treatment of the First Metatarsophalangeal Osteoarthritis (Hallux Rigidus): The REPAR Trial

Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders · Published 2022-01-01 · DOI 10.1177/11795441211055882

Authors being retrieved — see the publisher record. https://doi.org/10.1177/11795441211055882

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2022

Related articles